Pricing Log in Create free account
Friday 6 November 2026 Export ITGR’s income statement to Excel — free account

Integer Holdings Corporation

ITGR Healthcare Medical Devices

Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024.

Revenue
−3.86%
EPS
−61.0%
Free cash flow
−65.2%
Total debt
+4.06%

Quarter to September 2026, against a year earlier

126.56 0.19 −0.15%
Market cap
$4.3B
P/E
42.2×
Fwd P/E
38.9×
Dividend yield
—
F-score
6/9
Altman Z
2.34
Beneish M
−2.30
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Integer Holdings Corporation (ITGR) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Integer Holdings Corporation (ITGR) trades at a EV/EBITDA of 18.8×. Over the past ten years it has ranged from 9.6× (October 2025) to 41.9× (December 2015); the current reading is higher than 91% of that period. That is above the Medical Devices industry median of 11.5× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 10.9× (34.82%)
FY2024 16.8× 7.09%
FY2023 15.7× 1.84%
FY2022 15.4× (5.44%)
FY2021 16.3× (0.64%)
FY2020 16.4× 16.19%
FY2019 14.1× 23.39%
FY2018 11.4× (8.89%)
FY2017 12.5× (7.69%)
FY2016 13.6× (67.60%)

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 18.7× 36.25%
Jun 2026 13.7× 10.32%
Mar 2026 12.5× 14.04%
Dec 2025 10.9× (19.44%)
43 more quarters

Against its own ten years

Low 9.6× High 41.9×
Ten-year median 15.1×
Current reading's percentile 91

EV/EBITDA against peers

Company EV/EBITDA
AXGN AxoGen, Inc. compare n/m
TXG 10x Genomics compare n/m
LIVN LivaNova PLC compare 17.6×
ITGR Integer Holdings Corporation 18.8×
UFPT UFP Technologies, Inc. compare 20.5×
TMDX TransMedics Group, Inc. compare 22.0×
HAE Haemonetics Corporation compare 23.6×
NEOG Neogen Corporation compare 27.2×
IRTC iRhythm Holdings, Inc. compare 2,944×
Medical Devices industry median 11.5×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on ITGR